Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 — Charlotte, North Carolina

Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 is a clinical research site located in Charlotte, North Carolina, United States 28287.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colitis Ulcerative.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008?

Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 conducted?

Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 has 1 clinical trials on record, with 1 currently active. Their work covers Colitis Ulcerative.

Is Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 accredited by Crixeo Health?

Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.